Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
William H. Chappell, Brian D. Lehmann, David M. Terrian, Stephen L. Abrams, Linda S. Steelman & James A. McCubrey. (2012) p53 expression controls prostate cancer sensitivity to chemotherapy and the MDM2 inhibitor Nutlin-3. Cell Cycle 11:24, pages 4579-4588.
Read now
Read now
Linda S. Steelman, Patrick Navolanic, William H. Chappell, Stephen L. Abrams, Ellis W.T. Wong, Alberto M. Martelli, Lucio Cocco, Franca Stivala, Massimo Libra, Ferdinando Nicoletti, Lyudmyla B. Drobot, Richard A. Franklin & James A. McCubrey. (2011) Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells. Cell Cycle 10:17, pages 3003-3015.
Read now
Read now
Articles from other publishers (65)
Tareq Saleh, Sarah Bloukh, Mira Hasan & Sofian Al Shboul. (2023) Therapy-induced senescence as a component of tumor biology: Evidence from clinical cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:6, pages 188994.
Crossref
Crossref
Saheed Oluwasina Oseni, Corey Naar, Mirjana Pavlović, Waseem Asghar, James X. Hartmann, Gregg B. Fields, Nwadiuto Esiobu & James Kumi-Diaka. (2023) The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer. Cancers 15:12, pages 3110.
Crossref
Crossref
Julia Kallenbach, Golnaz Atri Roozbahani, Mehdi Heidari Horestani & Aria Baniahmad. (2022) Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer. Cell & Bioscience 12:1.
Crossref
Crossref
Ryuji Okazaki. (2022) Role of p53 in Regulating Radiation Responses. Life 12:7, pages 1099.
Crossref
Crossref
Stephen L. Abrams, Przemysław Duda, Shaw M. Akula, Linda S. Steelman, Matilde L. Follo, Lucio Cocco, Stefano Ratti, Alberto M. Martelli, Giuseppe Montalto, Maria Rita Emma, Melchiorre Cervello, Dariusz Rakus, Agnieszka Gizak & James A. McCubrey. (2022) Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53. Cells 11:5, pages 794.
Crossref
Crossref
Raik Schneider, Günther Gademann, Hans-Joachim Ochel, Karsten Neumann, Burkhard Jandrig, Peter Hass, Mathias Walke, Martin Schostak, Thomas Brunner & Frank Christoph. (2021) Functional and mutational analysis after radiation and cetuximab treatment on prostate carcinoma cell line DU145. Radiation Oncology 16:1.
Crossref
Crossref
D.M. Zhang, J. Szymanski, C. Bergom, P.S. Cuculich, C.G. Robinson, J.K. Schwarz & S.L. Rentschler. (2021) Leveraging Radiobiology for Arrhythmia Management: A New Treatment Paradigm?. Clinical Oncology 33:11, pages 723-734.
Crossref
Crossref
Sahar El Hadad, Eman Al Rowily, Alia Aldahlawi, Jehan Alrahimi & Shahira Hassoubah. (2021) The Role of P53 and K-Ras in Regulating Spleen Innate Mediators in Mice with Colon Cancer. Pharmacophore 12:4, pages 19-27.
Crossref
Crossref
Stephen L. Abrams, Shaw M. Akula, Alberto M. Martelli, Lucio Cocco, Stefano Ratti, Massimo Libra, Saverio Candido, Giuseppe Montalto, Melchiorre Cervello, Agnieszka Gizak, Dariusz Rakus, Linda S. Steelman & James A. McCubrey. (2021) Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53. Advances in Biological Regulation 79, pages 100780.
Crossref
Crossref
Beata Hat, Joanna Jaruszewicz-Błońska & Tomasz Lipniacki. (2020) Model-based optimization of combination protocols for irradiation-insensitive cancers. Scientific Reports 10:1.
Crossref
Crossref
Evan McNabb, Azza Al-Mahrouki, Niki Law, Scott McKay, Christine Tarapacki, Farah Hussein & Gregory J. Czarnota. (2020) Ultrasound-stimulated microbubble radiation enhancement of tumors: Single-dose and fractionated treatment evaluation. PLOS ONE 15:9, pages e0239456.
Crossref
Crossref
Magdalena Niemira, Barbara Borowa-Mazgaj, Samuel B. Bader, Adrianna Moszyńska, Marcin Ratajewski, Kaja Karaś, Mirosław Kwaśniewski, Adam Krętowski, Zofia Mazerska, Ester M. Hammond & Anna Skwarska. (2020) Anticancer Imidazoacridinone C-1311 is Effective in Androgen-Dependent and Androgen-Independent Prostate Cancer Cells. Biomedicines 8:9, pages 292.
Crossref
Crossref
Nipa H. Patel, Sahib S. Sohal, Masoud H Manjili, J. Chuck Harrell & David A. Gewirtz. (2020) The Roles of Autophagy and Senescence in the Tumor Cell Response to Radiation. Radiation Research 194:2, pages 103.
Crossref
Crossref
William H. Chappell, Saverio Candido, Stephen L. Abrams, Shaw M. Akula, Linda S. Steelman, Alberto M. Martelli, Stefano Ratti, Lucio Cocco, Melchiorre Cervello, Giuseppe Montalto, Ferdinando Nicoletti, Massimo Libra & James A. McCubrey. (2020) Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines. Aging 12:11, pages 10194-10210.
Crossref
Crossref
Emarndeena H. Cheteh, Victoria Sarne, Sophia Ceder, Julie Bianchi, Martin Augsten, Helene Rundqvist, Lars Egevad, Arne Östman & Klas G. Wiman. (2020) Interleukin-6 derived from cancer-associated fibroblasts attenuates the p53 response to doxorubicin in prostate cancer cells. Cell Death Discovery 6:1.
Crossref
Crossref
Yasir I. Mohammed Saleem, Hussam Albassam & Mustafa Selim. (2019) Urolithin A induces prostate cancer cell death in p53-dependent and in p53-independent manner. European Journal of Nutrition 59:4, pages 1607-1618.
Crossref
Crossref
Carla Pisani, Martina Ramella, Renzo Boldorini, Gianfranco Loi, Michele Billia, Francesca Boccafoschi, Alessandro Volpe & Marco Krengli. (2020) Apoptotic and predictive factors by Bax, Caspases 3/9, Bcl-2, p53 and Ki-67 in prostate cancer after 12 Gy single-dose. Scientific Reports 10:1.
Crossref
Crossref
Saverio Candido, Stephen L. Abrams, Linda S. Steelman, Kvin Lertpiriyapong, Alberto M. Martelli, Lucio Cocco, Stefano Ratti, Matilde Y. Follo, Ramiro M. Murata, Pedro L. Rosalen, Bruno Bueno-Silva, Severino Matias de Alencar, Paolo Lombardi, Weifeng Mao, Giuseppe Montalto, Melchiorre Cervello, Dariusz Rakus, Agnieska Gizak, Heng-Liang Lin, Massimo Libra, Shaw M. Akula & James A. McCubrey. (2019) Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals. Advances in Biological Regulation 72, pages 22-40.
Crossref
Crossref
Timothy M. Fan & Kimberly A. Selting. (2019) Exploring the Potential Utility of Pet Dogs With Cancer for Studying Radiation-Induced Immunogenic Cell Death Strategies. Frontiers in Oncology 8.
Crossref
Crossref
Stephen L. Abrams, Kvin Lertpiriyapong, Li V. Yang, Alberto M. Martelli, Lucio Cocco, Stefano Ratti, Marco Falasca, Ramiro M. Murata, Pedro L. Rosalen, Paolo Lombardi, Massimo Libra, Saverio Candido, Giuseppe Montalto, Melchiorre Cervello, Linda S. Steelman & James A. McCubrey. (2018) Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals. Advances in Biological Regulation 69, pages 16-34.
Crossref
Crossref
William H. Chappell, Saverio Candido, Stephen L. Abrams, Suzanne Russo, Roger Ove, Alberto M. Martelli, Lucio Cocco, Giulia Ramazzotti, Melchiorre Cervello, Giuseppe Montalto, Linda S. Steelman, Xiaohong Leng, Ralph B. Arlinghaus, Massimo Libra & James A. McCubrey. (2018) Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines. Advances in Biological Regulation 69, pages 43-62.
Crossref
Crossref
Mathias Tesson, Richa Vasan, Andreas Hock, Colin Nixon, Colin Rae, Mark Gaze & Robert Mairs. (2018)
An evaluation
in vitro
of the efficacy of nutlin-3 and topotecan in combination with 177Lu-DOTATATE for the treatment of neuroblastoma
. Oncotarget 9:49, pages 29082-29096.
Crossref
Crossref
Fernando M. Simabuco, Mirian G. Morale, Isadora C.B. Pavan, Ana P. Morelli, Fernando R. Silva & Rodrigo E. Tamura. (2018) p53 and metabolism: from mechanism to therapeutics. Oncotarget 9:34, pages 23780-23823.
Crossref
Crossref
Laura E. Pascal, Yao Wang, Mingming Zhong, Dan Wang, Anish Bhaswanth Chakka, Zhenyu Yang, Feng Li, Qiong Song, Lora H. Rigatti, Srilakshmi Chaparala, Uma Chandran, Anil V. Parwani & Zhou Wang. (2018) EAF2 and p53 Co-Regulate STAT3 Activation in Prostate Cancer. Neoplasia 20:4, pages 351-363.
Crossref
Crossref
Tianli He, Jiayou Guo, Hongmei Song, Hongcheng Zhu, Xiaoke Di, Hua Min, Yuandong Wang, Guangzong Chen, Wangshu Dai, Jianhua Ma, Xinchen Sun & Jianxin Ma. (2017) Nutlin-3, an Antagonist of MDM2, Enhances the Radiosensitivity of Esophageal Squamous Cancer with Wild-Type p53. Pathology & Oncology Research 24:1, pages 75-81.
Crossref
Crossref
Simone de Brot & Nigel P. Mongan. 2018. Precision Molecular Pathology of Prostate Cancer. Precision Molecular Pathology of Prostate Cancer
381
404
.
Haihui Chen, Mengxin Wu, Guisheng Li, Li Hua, Shaojun Chen & Haixin Huang. (2017) Association between XRCC1 single-nucleotide polymorphism and acute radiation reaction in patients with nasopharyngeal carcinoma. Medicine 96:44, pages e8202.
Crossref
Crossref
Stephen L. Abrams, Peter P. Ruvolo, Vivian R. Ruvolo, Giovanni Ligresti, Alberto M. Martelli, Lucio Cocco, Stefano Ratti, Agostino Tafuri, Linda S. Steelman, Saverio Candido, Massimo Libra & James A. McCubrey. (2017) Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells. Oncotarget 8:44, pages 76525-76557.
Crossref
Crossref
Yuan Liu, Tracy Murray-Stewart, Robert A. CaseroJrJr, Ioannis Kagiampakis, Lihua Jin, Jiawen Zhang, Huihui Wang, Qi Che, Huan Tong, Jieqi Ke, Feizhou Jiang, Fangyuan Wang & Xiaoping Wan. (2017) Targeting hexokinase 2 inhibition promotes radiosensitization in HPV16 E7-induced cervical cancer and suppresses tumor growth. International Journal of Oncology 50:6, pages 2011-2023.
Crossref
Crossref
James A. McCubrey, Kvin Lertpiriyapong, Timothy L. Fitzgerald, Alberto M. Martelli, Lucio Cocco, Dariusz Rakus, Agnieszka Gizak, Massimo Libra, Melchiorre Cervello, Guiseppe Montalto, Li V. Yang, Stephen L. Abrams & Linda S. Steelman. (2017) Roles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasis. Advances in Biological Regulation 63, pages 32-48.
Crossref
Crossref
C. Nicholson, I. Vela & E.D. Williams. 2017. Introduction to Cancer Metastasis. Introduction to Cancer Metastasis
33
59
.
Patrick Maier, Linda Hartmann, Frederik Wenz & Carsten Herskind. (2016) Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization. International Journal of Molecular Sciences 17:1, pages 102.
Crossref
Crossref
William H. Chappell, Stephen L. Abrams, Kvin Lertpiriyapong, Timothy L. Fitzgerald, Alberto M. Martelli, Lucio Cocco, Dariusz Rakus, Agnieszka Gizak, David Terrian, Linda S. Steelman & James A. McCubrey. (2016) Novel roles of androgen receptor, epidermal growth factor receptor, TP53, regulatory RNAs, NF-kappa-B, chromosomal translocations, neutrophil associated gelatinase, and matrix metalloproteinase-9 in prostate cancer and prostate cancer stem cells. Advances in Biological Regulation 60, pages 64-87.
Crossref
Crossref
Lauryn R. Werner, Shyhmin Huang, David M. Francis, Eric A. Armstrong, Fang Ma, Chunrong Li, Gopal Iyer, Jude Canon & Paul M. Harari. (2015) Small Molecule Inhibition of MDM2–p53 Interaction Augments Radiation Response in Human Tumors. Molecular Cancer Therapeutics 14:9, pages 1994-2003.
Crossref
Crossref
Josephine Salimu, Lisa K. Spary, Saly Al-Taei, Aled Clayton, Malcolm D. Mason, John Staffurth & Zsuzsanna Tabi. (2015) Cross-Presentation of the Oncofetal Tumor Antigen 5T4 from Irradiated Prostate Cancer Cells—A Key Role for Heat-Shock Protein 70 and Receptor CD91. Cancer Immunology Research 3:6, pages 678-688.
Crossref
Crossref
M M Chitnis, K A Lodhia, T Aleksic, S Gao, A S Protheroe & V M Macaulay. (2013) IGF-1R inhibition enhances radiosensitivity and delays double-strand break repair by both non-homologous end-joining and homologous recombination. Oncogene 33:45, pages 5262-5273.
Crossref
Crossref
James A. McCubrey, Nicole M. Davis, Stephen L. Abrams, Giuseppe Montalto, Melchiorre Cervello, Massimo Libra, Ferdinando Nicoletti, Antonino B. D'Assoro, Lucio Cocco, Alberto M. Martelli & Linda S. Steelman. (2014) Targeting breast cancer initiating cells: Advances in breast cancer research and therapy. Advances in Biological Regulation 56, pages 81-107.
Crossref
Crossref
Liangfang Shen, Xinqiong Huang, Xiaoxue Xie, Juan Su, Jun Yuan & Xiang Chen. (2014) High Expression of SOX2 and OCT4 Indicates Radiation Resistance and an Independent Negative Prognosis in Cervical Squamous Cell Carcinoma. Journal of Histochemistry & Cytochemistry 62:7, pages 499-509.
Crossref
Crossref
Kian Hoe Khoo, Chandra S. Verma & David P. Lane. (2014) Drugging the p53 pathway: understanding the route to clinical efficacy. Nature Reviews Drug Discovery 13:3, pages 217-236.
Crossref
Crossref
Richard Khor & Scott Williams. (2013) Contemporary Issues in Radiotherapy for Clinically Localized Prostate Cancer. Hematology/Oncology Clinics of North America 27:6, pages 1137-1162.
Crossref
Crossref
Daniela Schilling, Michael Düwel, Michael Molls & Gabriele Multhoff. (2012) Radiosensitization of wildtype p53 cancer cells by the MDM2-inhibitor PXN727 is associated with altered heat shock protein 70 (Hsp70) levels. Cell Stress and Chaperones 18:2, pages 183-191.
Crossref
Crossref
Raffaele Parrozzani, Elisabetta Pilotto, Alessia Dario, Giacomo Miglionico & Edoardo Midena. (2013) Intravitreal Triamcinolone Versus Intravitreal Bevacizumab in the Treatment of Exudative Retinal Detachment Secondary to Posterior Uveal Melanoma. American Journal of Ophthalmology 155:1, pages 127-133.e2.
Crossref
Crossref
Veronica Huber, Paola Filipazzi & Licia Rivoltini. 2013. Cancer Immunotherapy. Cancer Immunotherapy
517
535
.
Paola Filipazzi, Maja Bürdek, Antonello Villa, Licia Rivoltini & Veronica Huber. (2012) Recent advances on the role of tumor exosomes in immunosuppression and disease progression. Seminars in Cancer Biology 22:4, pages 342-349.
Crossref
Crossref
Heath D. Skinner, Vlad C. Sandulache, Thomas J. Ow, Raymond E. Meyn, John S. Yordy, Beth M. Beadle, Alison L. Fitzgerald, Uma Giri, K. Kian Ang & Jeffrey N. Myers. (2012)
TP53
Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced Senescence
. Clinical Cancer Research 18:1, pages 290-300.
Crossref
Crossref
James A. McCubrey, Stephen L. Abrams, Kazuo Umezawa, Lucio Cocco, Alberto M. Martelli, Richard A. Franklin, William H. Chappell & Linda S. Steelman. (2012) Novel approaches to target cancer initiating cells–Eliminating the root of the cancer. Advances in Biological Regulation 52:1, pages 249-264.
Crossref
Crossref
Jackson R. Taylor, Brian D. Lehmann, William H. Chappell, Stephen L. Abrams, Linda S. Steelman & James A. McCubrey. (2011) Cooperative Effects of Akt-1 and Raf-1 on the Induction of Cellular Senescence in Doxorubicin or Tamoxifen Treated Breast Cancer Cells. Oncotarget 2:8, pages 610-626.
Crossref
Crossref
Yunguang Tong, Weijiang Zhao, Cuiqi Zhou, Kolja Wawrowsky & Shlomo Melmed. (2011) PTTG1 Attenuates Drug-Induced Cellular Senescence. PLoS ONE 6:8, pages e23754.
Crossref
Crossref
James A. McCubrey, William H. Chappell, Stephen L. Abrams, Richard A. Franklin, Jacquelyn M. Long, Jennifer A. Sattler, C. Ruth Kempf, Piotr Laidler & Linda S. Steelman. (2011) Targeting the cancer initiating cell: The Achilles’ heel of cancer. Advances in Enzyme Regulation 51:1, pages 152-162.
Crossref
Crossref
David Eriksson & Torgny Stigbrand. (2010) Radiation-induced cell death mechanisms. Tumor Biology 31:4, pages 363-372.
Crossref
Crossref
Liang-Fang Shen, Jia Chen, Shan Zeng, Rong-Rong Zhou, Hong Zhu, Mei-Zuo Zhong, Ruo-Jing Yao & Hong Shen. (2010)
The Superparamagnetic Nanoparticles Carrying the
E1A
Gene Enhance the Radiosensitivity of Human Cervical Carcinoma in Nude Mice
. Molecular Cancer Therapeutics 9:7, pages 2123-2130.
Crossref
Crossref
A K Arya, A El-Fert, T Devling, R M Eccles, M A Aslam, C P Rubbi, N Vlatković, J Fenwick, B H Lloyd, D R Sibson, T M Jones & M T Boyd. (2010) Nutlin-3, the small-molecule inhibitor of MDM2, promotes senescence and radiosensitises laryngeal carcinoma cells harbouring wild-type p53. British Journal of Cancer 103:2, pages 186-195.
Crossref
Crossref
Ilaria Postiglione, Angela Chiaviello & Giuseppe Palumbo. (2009) Twilight effects of low doses of ionizing radiation on cellular systems: a bird’s eye view on current concepts and research. Medical Oncology 27:2, pages 495-509.
Crossref
Crossref
Laurent Quéro, Nicole Giocanti, Christophe Hennequin & Vincent Favaudon. (2009) Antagonistic interaction between bicalutamide™ (Casodex®) and radiation in androgen‐positive prostate cancer LNCaP cells. The Prostate 70:4, pages 401-411.
Crossref
Crossref
James A. McCubrey, Stephen L. Abrams, Kristin Stadelman, William H. Chappell, Michelle LaHair, Richard A. Ferland & Linda S. Steelman. (2010) Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells. Advances in Enzyme Regulation 50:1, pages 285-307.
Crossref
Crossref
Grzegorz Sarek & Päivi M. Ojala. 2010. Molecular Basis for Therapy of AIDS-Defining Cancers. Molecular Basis for Therapy of AIDS-Defining Cancers
167
180
.
N Misaghian, G Ligresti, L S Steelman, F E Bertrand, J Bäsecke, M Libra, F Nicoletti, F Stivala, M Milella, A Tafuri, M Cervello, A M Martelli & J A McCubrey. (2008) Targeting the leukemic stem cell: the Holy Grail of leukemia therapy. Leukemia 23:1, pages 25-42.
Crossref
Crossref
J A McCubrey, S L Abrams, G Ligresti, N Misaghian, E W T Wong, L S Steelman, J Bäsecke, J Troppmair, M Libra, F Nicoletti, S Molton, M McMahon, C Evangelisti & A M Martelli. (2008) Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance. Leukemia 22:11, pages 2080-2090.
Crossref
Crossref
Brian D. Lehmann, Matthew S. Paine, Adam M. Brooks, James A. McCubrey, Randall H. Renegar, Rong Wang & David M. Terrian. (2008) Senescence-Associated Exosome Release from Human Prostate Cancer Cells. Cancer Research 68:19, pages 7864-7871.
Crossref
Crossref
David A. Gewirtz, Shawn E. Holt & Lynne W. Elmore. (2008) Accelerated senescence: An emerging role in tumor cell response to chemotherapy and radiation. Biochemical Pharmacology 76:8, pages 947-957.
Crossref
Crossref
L S Steelman, P M Navolanic, M L Sokolosky, J R Taylor, B D Lehmann, W H Chappell, S L Abrams, E W T Wong, K M Stadelman, D M Terrian, N R Leslie, A M Martelli, F Stivala, M Libra, R A Franklin & J A McCubrey. (2008) Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors. Oncogene 27:29, pages 4086-4095.
Crossref
Crossref
L. Marignol, M. Coffey, M. Lawler & D. Hollywood. (2008) Hypoxia in prostate cancer: A powerful shield against tumour destruction?. Cancer Treatment Reviews 34:4, pages 313-327.
Crossref
Crossref
James A. McCubrey, Melissa L. Sokolosky, Brian D. Lehmann, Jackson R. Taylor, Patrick M. Navolanic, William H. Chappell, Stephen L. Abrams, Kristin M. Stadelman, Ellis W.T. Wong, Negin Misaghian, Stefan Horn, Jörg Bäsecke, Massimo Libra, Franca Stivala, Giovanni Ligresti, Agostino Tafuri, Michele Milella, Marek Zarzycki, Andrzej Dzugaj, Francesca Chiarini, Camilla Evangelisti, Alberto M. Martelli, David M. Terrian, Richard A. Franklin & Linda S. Steelman. (2008) Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy. Advances in Enzyme Regulation 48:1, pages 113-135.
Crossref
Crossref
James A. McCubrey, Richard A. Franklin, Fred E. Bertrand, Jackson R. Taylor, William H. Chappell, Melissa L. Midgett, Ellis W. T. Wong, Stephen L. Abrams, Kristin M. Stadelman, Negin Misaghian, Dale L. Ludwig, Jorg Basecke, Massimo Libra, Franca Stivala, Michele Milella, Agostino Tafuri, Alberto M. Martelli, Paolo Lungi, Antonio Bonati, David M. Terrian, Brian D. Lehmann & Linda S. Steelman. 2008. Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy. Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy
81
114
.
David Eriksson, Katrine Riklund, Lennart Johansson & Torgny Stigbrand. 2008. Targeted Radionuclide Tumor Therapy. Targeted Radionuclide Tumor Therapy
215
248
.